Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis

BACKGROUND: The efficacy and safety of ambrisentan has been previously evaluated in Chinese patients with pulmonary arterial hypertension (PAH). This post-hoc analysis assessed the efficacy and safety of ambrisentan in a subgroup of connective tissue disease (CTD) patients with PAH. METHODS: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengtao, Jing, Zhi-Cheng, Li, Yang, Huo, Yong, Yu, Zaixin, Zhang, Gangcheng, Zhu, Ping, Liu, Jinming, Ji, Qiushang, Wu, Bingxiang, Zhong, Jinhua, Wang, Pingping, Zhu, Wenjing, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367256/
https://www.ncbi.nlm.nih.gov/pubmed/32680480
http://dx.doi.org/10.1186/s12872-020-01591-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367256/
https://www.ncbi.nlm.nih.gov/pubmed/32680480
http://dx.doi.org/10.1186/s12872-020-01591-1

Ejemplares similares